By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news157718167.html">By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies</a></p> <p>Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.</p>